nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B1—polycystic ovary syndrome	0.445	0.597	CbGaD
Trilostane—HSD3B2—polycystic ovary syndrome	0.301	0.403	CbGaD
Trilostane—HSD3B1—corpus luteum—polycystic ovary syndrome	0.03	0.286	CbGeAlD
Trilostane—HSD3B1—ovarian follicle—polycystic ovary syndrome	0.0234	0.224	CbGeAlD
Trilostane—HSD3B2—ovarian follicle—polycystic ovary syndrome	0.0186	0.177	CbGeAlD
Trilostane—ESR2—ovarian follicle—polycystic ovary syndrome	0.00606	0.0579	CbGeAlD
Trilostane—ESR1—ovarian follicle—polycystic ovary syndrome	0.00415	0.0396	CbGeAlD
Trilostane—HSD3B1—adrenal cortex—polycystic ovary syndrome	0.0026	0.0248	CbGeAlD
Trilostane—HSD3B2—adrenal cortex—polycystic ovary syndrome	0.00206	0.0196	CbGeAlD
Trilostane—HSD3B1—adrenal gland—polycystic ovary syndrome	0.00188	0.0179	CbGeAlD
Trilostane—HSD3B1—female gonad—polycystic ovary syndrome	0.00175	0.0167	CbGeAlD
Trilostane—HSD3B2—pituitary gland—polycystic ovary syndrome	0.00166	0.0159	CbGeAlD
Trilostane—HSD3B1—endocrine gland—polycystic ovary syndrome	0.00163	0.0155	CbGeAlD
Trilostane—HSD3B2—adrenal gland—polycystic ovary syndrome	0.00149	0.0142	CbGeAlD
Trilostane—HSD3B2—female gonad—polycystic ovary syndrome	0.00139	0.0132	CbGeAlD
Trilostane—HSD3B2—endocrine gland—polycystic ovary syndrome	0.00129	0.0123	CbGeAlD
Trilostane—ESR2—endometrium—polycystic ovary syndrome	0.0006	0.00572	CbGeAlD
Trilostane—Stanozolol—AR—polycystic ovary syndrome	0.000565	0.121	CrCbGaD
Trilostane—ESR1—embryo—polycystic ovary syndrome	0.000561	0.00536	CbGeAlD
Trilostane—ESR2—uterus—polycystic ovary syndrome	0.000553	0.00528	CbGeAlD
Trilostane—ESR2—pituitary gland—polycystic ovary syndrome	0.000543	0.00518	CbGeAlD
Trilostane—Oxandrolone—AR—polycystic ovary syndrome	0.000508	0.109	CrCbGaD
Trilostane—ESR2—adrenal gland—polycystic ovary syndrome	0.000485	0.00463	CbGeAlD
Trilostane—ESR2—female gonad—polycystic ovary syndrome	0.000452	0.00432	CbGeAlD
Trilostane—ESR2—vagina—polycystic ovary syndrome	0.000449	0.00429	CbGeAlD
Trilostane—ESR2—endocrine gland—polycystic ovary syndrome	0.00042	0.00401	CbGeAlD
Trilostane—ESR1—endometrium—polycystic ovary syndrome	0.000411	0.00392	CbGeAlD
Trilostane—Drostanolone—SHBG—polycystic ovary syndrome	0.000386	0.0825	CrCbGaD
Trilostane—ESR1—uterus—polycystic ovary syndrome	0.000378	0.00361	CbGeAlD
Trilostane—ESR1—pituitary gland—polycystic ovary syndrome	0.000372	0.00355	CbGeAlD
Trilostane—ESR1—adipose tissue—polycystic ovary syndrome	0.00037	0.00353	CbGeAlD
Trilostane—Drostanolone—AR—polycystic ovary syndrome	0.000338	0.0723	CrCbGaD
Trilostane—ESR1—adrenal gland—polycystic ovary syndrome	0.000332	0.00317	CbGeAlD
Trilostane—ESR1—female gonad—polycystic ovary syndrome	0.00031	0.00296	CbGeAlD
Trilostane—ESR1—vagina—polycystic ovary syndrome	0.000308	0.00294	CbGeAlD
Trilostane—ESR1—endocrine gland—polycystic ovary syndrome	0.000288	0.00275	CbGeAlD
Trilostane—Drostanolone—CYP19A1—polycystic ovary syndrome	0.000283	0.0605	CrCbGaD
Trilostane—Danazol—PGR—polycystic ovary syndrome	0.000223	0.0477	CrCbGaD
Trilostane—Danazol—SHBG—polycystic ovary syndrome	0.000208	0.0445	CrCbGaD
Trilostane—Danazol—AR—polycystic ovary syndrome	0.000183	0.0391	CrCbGaD
Trilostane—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000176	0.0376	CrCbGaD
Trilostane—Progesterone—CYP17A1—polycystic ovary syndrome	0.000156	0.0333	CrCbGaD
Trilostane—Methyltestosterone—AR—polycystic ovary syndrome	0.000154	0.033	CrCbGaD
Trilostane—Danazol—CYP19A1—polycystic ovary syndrome	0.000153	0.0327	CrCbGaD
Trilostane—Testosterone—CYP11A1—polycystic ovary syndrome	0.000145	0.031	CrCbGaD
Trilostane—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000129	0.0276	CrCbGaD
Trilostane—Estradiol—SHBG—polycystic ovary syndrome	0.000127	0.0272	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000123	0.000855	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000122	0.000846	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000122	0.000843	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00012	0.00083	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000119	0.000825	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000118	0.000817	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000116	0.000806	CbGpPWpGaD
Trilostane—Progesterone—PGR—polycystic ovary syndrome	0.000116	0.0247	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000113	0.000783	CbGpPWpGaD
Trilostane—Estradiol—AR—polycystic ovary syndrome	0.000112	0.0239	CrCbGaD
Trilostane—HSD3B1—Metabolism—TEAD2—polycystic ovary syndrome	0.000111	0.000769	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000111	0.000769	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000111	0.000769	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—AR—polycystic ovary syndrome	0.000109	0.000752	CbGpPWpGaD
Trilostane—Progesterone—SHBG—polycystic ovary syndrome	0.000108	0.0231	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000107	0.000739	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000106	0.000737	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SUOX—polycystic ovary syndrome	0.000106	0.000737	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000105	0.000728	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000105	0.000728	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000105	0.000724	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PGR—polycystic ovary syndrome	0.000104	0.000717	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000103	0.000711	CbGpPWpGaD
Trilostane—Testosterone—SHBG—polycystic ovary syndrome	0.000102	0.0218	CrCbGaD
Trilostane—ESR2—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000102	0.000706	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ISYNA1—polycystic ovary syndrome	9.89e-05	0.000685	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—NR3C1—polycystic ovary syndrome	9.88e-05	0.000684	CbGpPWpGaD
Trilostane—ESR1—Signaling events mediated by HDAC Class II—NR3C1—polycystic ovary syndrome	9.88e-05	0.000684	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	9.67e-05	0.00067	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—TH—polycystic ovary syndrome	9.66e-05	0.000669	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	9.65e-05	0.000668	CbGpPWpGaD
Trilostane—Progesterone—AR—polycystic ovary syndrome	9.47e-05	0.0202	CrCbGaD
Trilostane—ESR1—Estrogen signaling pathway—BCL2—polycystic ovary syndrome	9.47e-05	0.000656	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	9.38e-05	0.000649	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	9.38e-05	0.000649	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PNPLA2—polycystic ovary syndrome	9.3e-05	0.000644	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	9.03e-05	0.000625	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ZNF205—polycystic ovary syndrome	8.95e-05	0.00062	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ZNF430—polycystic ovary syndrome	8.95e-05	0.00062	CbGpPWpGaD
Trilostane—Testosterone—AR—polycystic ovary syndrome	8.95e-05	0.0191	CrCbGaD
Trilostane—HSD3B1—Metabolism—SRD5A1—polycystic ovary syndrome	8.82e-05	0.000611	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	8.8e-05	0.000609	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	8.69e-05	0.000602	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	8.56e-05	0.000593	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	8.56e-05	0.000593	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TH—polycystic ovary syndrome	8.42e-05	0.000583	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TEAD2—polycystic ovary syndrome	8.41e-05	0.000582	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C2—polycystic ovary syndrome	8.41e-05	0.000582	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—STAR—polycystic ovary syndrome	8.41e-05	0.000582	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PRL—polycystic ovary syndrome	8.4e-05	0.000581	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	8.33e-05	0.000577	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.31e-05	0.000576	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	8.09e-05	0.00056	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.96e-05	0.000551	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	7.83e-05	0.000542	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	7.81e-05	0.000541	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PPARG—polycystic ovary syndrome	7.65e-05	0.00053	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ADARB1—polycystic ovary syndrome	7.61e-05	0.000527	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HMMR—polycystic ovary syndrome	7.5e-05	0.000519	CbGpPWpGaD
Trilostane—Testosterone—CYP19A1—polycystic ovary syndrome	7.49e-05	0.016	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.07e-05	0.00049	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PNPLA2—polycystic ovary syndrome	7.05e-05	0.000488	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—polycystic ovary syndrome	7.04e-05	0.000487	CbGpPWpGaD
Trilostane—Estradiol—CYP1A1—polycystic ovary syndrome	6.87e-05	0.0147	CrCbGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—IGF1—polycystic ovary syndrome	6.83e-05	0.000473	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.7e-05	0.000464	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SRD5A1—polycystic ovary syndrome	6.68e-05	0.000463	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—INS—polycystic ovary syndrome	6.67e-05	0.000462	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	6.67e-05	0.000462	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	6.66e-05	0.000461	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LHB—polycystic ovary syndrome	6.52e-05	0.000452	CbGpPWpGaD
Trilostane—Progesterone—NR3C1—polycystic ovary syndrome	6.42e-05	0.0137	CrCbGaD
Trilostane—ESR1—Signaling by ERBB4—FGF18—polycystic ovary syndrome	6.41e-05	0.000444	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—STAR—polycystic ovary syndrome	6.38e-05	0.000441	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HSD3B2—polycystic ovary syndrome	6.38e-05	0.000441	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	6.33e-05	0.000438	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.3e-05	0.000436	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	6.23e-05	0.000431	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—LSM5—polycystic ovary syndrome	6.21e-05	0.00043	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C1—polycystic ovary syndrome	6.17e-05	0.000428	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	6.06e-05	0.00042	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	6.05e-05	0.000419	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—BAX—polycystic ovary syndrome	6.04e-05	0.000418	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—YAP1—polycystic ovary syndrome	5.93e-05	0.000411	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GAB1—polycystic ovary syndrome	5.85e-05	0.000405	CbGpPWpGaD
Trilostane—Progesterone—CYP1A1—polycystic ovary syndrome	5.83e-05	0.0125	CrCbGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	5.83e-05	0.000404	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SAP30L—polycystic ovary syndrome	5.77e-05	0.0004	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SULT2A1—polycystic ovary syndrome	5.68e-05	0.000393	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMMR—polycystic ovary syndrome	5.68e-05	0.000393	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	5.67e-05	0.000393	CbGpPWpGaD
Trilostane—Testosterone—CYP1A1—polycystic ovary syndrome	5.51e-05	0.0118	CrCbGaD
Trilostane—HSD3B1—Metabolism—RRM2—polycystic ovary syndrome	5.5e-05	0.000381	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HSD3B1—polycystic ovary syndrome	5.42e-05	0.000375	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	5.39e-05	0.000373	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.36e-05	0.000371	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—YAP1—polycystic ovary syndrome	5.3e-05	0.000367	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—INS—polycystic ovary syndrome	5.28e-05	0.000365	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	5.23e-05	0.000362	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PGR—polycystic ovary syndrome	5.18e-05	0.000359	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	5.14e-05	0.000356	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—LEP—polycystic ovary syndrome	5.1e-05	0.000353	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NAMPT—polycystic ovary syndrome	5.1e-05	0.000353	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.08e-05	0.000352	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.07e-05	0.000351	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP11A1—polycystic ovary syndrome	5.03e-05	0.000349	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5e-05	0.000346	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LHB—polycystic ovary syndrome	4.94e-05	0.000342	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TEAD2—polycystic ovary syndrome	4.91e-05	0.00034	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	4.87e-05	0.000337	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C3—polycystic ovary syndrome	4.75e-05	0.000329	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP17A1—polycystic ovary syndrome	4.68e-05	0.000324	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C1—polycystic ovary syndrome	4.68e-05	0.000324	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	4.62e-05	0.00032	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IRS1—polycystic ovary syndrome	4.55e-05	0.000315	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ZNF430—polycystic ovary syndrome	4.51e-05	0.000313	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ZNF205—polycystic ovary syndrome	4.51e-05	0.000313	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	4.46e-05	0.000309	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	4.32e-05	0.000299	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SULT2A1—polycystic ovary syndrome	4.31e-05	0.000298	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	4.26e-05	0.000295	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PGR—polycystic ovary syndrome	4.25e-05	0.000294	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PRL—polycystic ovary syndrome	4.2e-05	0.000291	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—RRM2—polycystic ovary syndrome	4.17e-05	0.000289	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	4.16e-05	0.000288	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	4.07e-05	0.000282	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	4.05e-05	0.000281	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TH—polycystic ovary syndrome	4.05e-05	0.00028	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—YAP1—polycystic ovary syndrome	4.02e-05	0.000278	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.96e-05	0.000274	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC2A4—polycystic ovary syndrome	3.94e-05	0.000273	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NAMPT—polycystic ovary syndrome	3.86e-05	0.000267	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.84e-05	0.000266	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ADARB1—polycystic ovary syndrome	3.84e-05	0.000266	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP11A1—polycystic ovary syndrome	3.81e-05	0.000264	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.79e-05	0.000262	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	3.76e-05	0.000261	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP19A1—polycystic ovary syndrome	3.7e-05	0.000256	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C3—polycystic ovary syndrome	3.6e-05	0.000249	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP17A1—polycystic ovary syndrome	3.55e-05	0.000246	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	3.52e-05	0.000244	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—RPL37A—polycystic ovary syndrome	3.5e-05	0.000242	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	3.46e-05	0.000239	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.45e-05	0.000239	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	3.45e-05	0.000239	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	3.36e-05	0.000232	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—AR—polycystic ovary syndrome	3.31e-05	0.000229	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GNAS—polycystic ovary syndrome	3.31e-05	0.000229	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NCOR1—polycystic ovary syndrome	3.15e-05	0.000218	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	3.13e-05	0.000217	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TH—polycystic ovary syndrome	3.07e-05	0.000212	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.04e-05	0.00021	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC2A4—polycystic ovary syndrome	2.98e-05	0.000207	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP1A1—polycystic ovary syndrome	2.98e-05	0.000207	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	2.96e-05	0.000205	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	2.94e-05	0.000203	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	2.94e-05	0.000203	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	2.91e-05	0.000201	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	2.89e-05	0.0002	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	2.86e-05	0.000198	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP19A1—polycystic ovary syndrome	2.81e-05	0.000194	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—polycystic ovary syndrome	2.78e-05	0.000193	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	2.67e-05	0.000185	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	2.6e-05	0.00018	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	2.59e-05	0.000179	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.58e-05	0.000179	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GNAS—polycystic ovary syndrome	2.5e-05	0.000173	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	2.47e-05	0.000171	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	2.46e-05	0.00017	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	2.39e-05	0.000166	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NCOR1—polycystic ovary syndrome	2.39e-05	0.000165	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—YAP1—polycystic ovary syndrome	2.34e-05	0.000162	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	2.31e-05	0.00016	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP1A1—polycystic ovary syndrome	2.26e-05	0.000157	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—polycystic ovary syndrome	2.26e-05	0.000156	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—POMC—polycystic ovary syndrome	2.23e-05	0.000154	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INS—polycystic ovary syndrome	2.21e-05	0.000153	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	2.14e-05	0.000148	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—polycystic ovary syndrome	2.11e-05	0.000146	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	2.1e-05	0.000146	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.1e-05	0.000145	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.07e-05	0.000143	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TNRC6B—polycystic ovary syndrome	2.07e-05	0.000143	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PGR—polycystic ovary syndrome	2.05e-05	0.000142	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	2.03e-05	0.000141	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	2.01e-05	0.000139	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	1.99e-05	0.000138	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.87e-05	0.000129	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	1.78e-05	0.000123	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	1.76e-05	0.000122	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.74e-05	0.000121	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—polycystic ovary syndrome	1.71e-05	0.000118	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—POMC—polycystic ovary syndrome	1.69e-05	0.000117	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INS—polycystic ovary syndrome	1.68e-05	0.000116	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	1.67e-05	0.000115	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	1.61e-05	0.000111	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AR—polycystic ovary syndrome	1.59e-05	0.00011	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	1.57e-05	0.000109	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	1.48e-05	0.000103	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	1.48e-05	0.000103	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	1.46e-05	0.000101	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NCOR1—polycystic ovary syndrome	1.39e-05	9.64e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	1.39e-05	9.61e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	1.35e-05	9.34e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	1.35e-05	9.33e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	1.31e-05	9.08e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.3e-05	9.02e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR3C1—polycystic ovary syndrome	1.29e-05	8.92e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	1.28e-05	8.85e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.19e-05	8.26e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	1.18e-05	8.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	1.09e-05	7.52e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	1.08e-05	7.49e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.04e-05	7.23e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	1.04e-05	7.22e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PGR—polycystic ovary syndrome	1.03e-05	7.15e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.02e-05	7.07e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—polycystic ovary syndrome	9.97e-06	6.91e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	9.94e-06	6.88e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	9.68e-06	6.71e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	9.56e-06	6.62e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	9.45e-06	6.54e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	9.41e-06	6.52e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	9.24e-06	6.4e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SERPINE1—polycystic ovary syndrome	8.98e-06	6.22e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	8.95e-06	6.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	8.86e-06	6.13e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	8.45e-06	5.85e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	8.3e-06	5.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	8.23e-06	5.7e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AR—polycystic ovary syndrome	8.03e-06	5.56e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	7.69e-06	5.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	7.58e-06	5.25e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	7.25e-06	5.02e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	7.02e-06	4.86e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.89e-06	4.77e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.78e-06	4.69e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	6.71e-06	4.65e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	6.49e-06	4.5e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	6.24e-06	4.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	6.24e-06	4.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	5.95e-06	4.12e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.8e-06	4.02e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	5.49e-06	3.8e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	5.44e-06	3.77e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.16e-06	3.58e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	5.03e-06	3.48e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.79e-06	3.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.56e-06	3.16e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	4.53e-06	3.14e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.48e-06	3.1e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.84e-06	2.66e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	3.75e-06	2.6e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.35e-06	2.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	3.22e-06	2.23e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	3.21e-06	2.22e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.1e-06	2.15e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.1e-06	2.15e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.95e-06	2.04e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.03e-06	1.4e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.4e-06	9.7e-06	CbGpPWpGaD
